FIELD: medicine; pharmacology.
SUBSTANCE: invention relates to biology and medicine, more specifically to biochemistry and pharmacology, and concerns the use of protatran 4-chloro-2-methylphenoxyacetate (chlorine crezacin) in 0.9 % sodium chloride, as a stimulator and static, and dynamic performance of transverse striated muscles. New property of chlorine crezacin is studied and described.
EFFECT: administering chlorine crezacin stimulates both static and dynamic operability.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF AN AQUEOUS SOLUTION OF PROTRAN 4-CHLORO-2-METHYLPHENOXYACETATE (CHLORINE CREZACIN) TO STIMULATE STATIC AND DYNAMIC OPERABILITY | 2019 |
|
RU2734899C1 |
| WORKING ABILITY IMPROVEMENT | 2014 |
|
RU2540476C1 |
| APPLICATION OF PROTATRAN 4-CHLORO-2-METHYLPHENOXYACETATE FOR EXHAUSTING OF MONONUCLEAR CELLS BASIC (ALKALINE) PHOSPHOLIPASE a2 TOTAL ACTIVITY | 2016 |
|
RU2619860C1 |
| BIS(µ-TARTRATO)DI(µ-HYDROXO)GERMANATE(IV) TRIETHANOLAMMONIUM INCREASING THE STATIC AND DYNAMIC PERFORMANCE | 2016 |
|
RU2661616C2 |
| SUBSTANCE STIMULATING GENE EXPRESSION OF COACTIVATOR PGC-1α | 2014 |
|
RU2559779C1 |
| USE OF 1-(HERMATRANE-1-YL)-1-OXYETHYLAMINE FOR INHIBITING TOTAL ACTIVITY OF BASIC (ALKALINE) PHOSPHOLIPASE A2 OF MONONUCLEAR CELLS | 2020 |
|
RU2732883C1 |
| APPLICATION OF PROTATRANE 4-CHLORO-2-METHYLPHENOXIACETATE (CHLORCREZACINE) FOR TRYPTOPHANYL-tRNA-SYNTHETASE MATRIX RNA EXPRESSION STIMULATION | 2016 |
|
RU2623035C1 |
| METHOD FOR SUPPRESSING TOTAL ACTIVITY OF BASIC (ALKALINE) PHOSPHOLIPASE A2 OF MONONUCLEAR CELLS USING 1-(HERMATRANE-1-YL)-1-OXYETHYLAMINE | 2020 |
|
RU2732881C1 |
| USE OF BIS(Μ-TARTRATO)DI(Μ-HYDROXO)GERMANATE (IV) TRIETHANOLAMMONIUM FOR INHIBITING TOTAL ACTIVITY OF BASIC (ALKALINE) PHOSPHOLIPASE A2 OF MONONUCLEAR CELLS | 2020 |
|
RU2733166C1 |
| METHOD OF INHIBITING TOTAL ACTIVITY OF BASIC (ALKALINE) PHOSPHOLIPASE A2 OF MONONUCLEAR CELLS USING BIS(Μ-TARTRATO)DI(Μ-HYDROXO)GERMANATE (IV) TRIETHANOLAMMONIUM | 2020 |
|
RU2732880C1 |
